Category Archives: Blog

PolarisQB Joins OpenFold AI Consortium along with Congruence, Biogen, Psivant and Others
DAVIS, Calif.--(BUSINESS WIRE)--OpenFold, a leading non-profit artificial intelligence (AI) research consortium focused on developing free and open source software tools for biology and drug discovery, today announced the addition of six new industry members. Joining the consortium are Astex Pharmaceuticals, Biogen, Congruence Therapeutics, Polaris Quantum Biotech, Psivant Therapeutics, and SandboxAQ, bringing unique expertise and a…
Read more
POLARISqb Receives DARPA IMPAQT Funding to Advance Quantum Computing for Drug Design
The Defense Advanced Research Project Agency (DARPA) awarded POLARISqb a research contract in support of their work designing drugs with quantum computers. The contract is a part of the Advanced Research Concept topic Imagining Practical Applications for a Quantum Tomorrow (IMPAQT). POLARISqb has been developing quantum computing methods for drug discovery since their inception in…
Read more
A Very Brief History of Very Large Numbers
What is the largest number of which you can conceive? This question has driven mathematicians and scientists for millennia, challenging the greatest minds of every era. In ancient India, a sacred text called the Yajurveda from around 1000 BCE named numbers based on the power of ten up to a quadrillion, or 1012. Building on…
Read more
White Paper on QuADD shows Marked Advantage Versus Conventional Library Builds
Polaris Quantum Biotech (POLARISqb) leverages quantum computing to accelerate drug discovery, revolutionizing the way that molecular drug design is accomplished. The company released a white paper on the advantages of using the POLARISqb platform Quantum-Aided Drug Design (QuADD) for library generation. An enriched starting library of diverse and drug-like molecules increases the probability of quickly…
Read more